CVL-871
Jump to navigation
Jump to search
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Clinical data | |
---|---|
Routes of administration | Oral administration |
Drug class | Dopamine receptor agonist |
CVL-871 is a dopamine receptor agonist which is under development for the treatment of dementia-related apathy.[1][2] It was originated by Pfizer and is under development by Cerevel Therapeutics.[1] CVL-871 acts as a selective partial agonist of the dopamine D1 and D5 receptors.[1][2][3] It is taken via oral administration.[1] As of April 2022, CVL-871 is in phase 2 clinical trials for dementia-related apathy.[1]
See also
- Tavapadon (CVL-751)
References
- ^ a b c d e "CVL 871 - AdisInsight".
- ^ a b Hatzipantelis CJ, Langiu M, Vandekolk TH, Pierce TL, Nithianantharajah J, Stewart GD, Langmead CJ (December 2020). "Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia". ACS Pharmacol Transl Sci. 3 (6): 1042–1062. doi:10.1021/acsptsci.0c00117. PMC 7737210. PMID 33344888.
- ^ "CVL-871 - Cerevel Therapeutics". 2 January 2020.
External links
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from May 2023
- All articles needing additional references
- Articles lacking reliable references from May 2023
- All articles lacking reliable references
- Articles with multiple maintenance issues
- Infobox drug articles without a structure image
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- D1-receptor agonists
- D5 receptor agonists
- Experimental drugs
- All stub articles
- Nervous system drug stubs